Randomized, double-blind, Placebo-Controlled Study to Compare the Efficacy of Combination of Lidocaine with ketorolac or triamcinolone versus Lidocaine Alone for Soft Tissue Injuries.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 32025137.
- Also identified by DOI 10.1016/j.jor.2020.01.043 and PMC identifier 6997642.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Corticosteroid and Ketorolac tromethamine is a pain reducing. The primary objective was pain intensity scores (VAS) in 10, 30, 60 min, 2, 6 h, 1, and 7 days. 120 patients were randomized. The placebo group (normal saline) and experimental groups (ketorolac 30 mg, 60 mg, triamcinolone 10 mg, 20 mg, and 40 mg, respectively) were compared. VAS at 60 min, 2, 6 h, 1 and 7 days was significantly different (P < 0.05). Ketorolac 30 mg, 60 mg, and triamcinolone 10 mg shown non inferiority to triamcinolone 40 mg. ketorolac was considered equal to triamcinolone.